Gotthardt Healthgroup AG
„Medical evidence to action“ is the leading idea behind the new venture Gotthardt Healthgroup AG and its digital health solutions & services. The mission is to have a positive, measurable impact on professional workflows, processes and everyday habits, across all players in healthcare and to generate meaningful insights into the realities of today’s healthcare processes. Payers, care givers, patients and families will benefit from new approaches.
Focus areas: Improved detection and management of diseases with a heavy burden on individuals or society, medication optimization, better and faster clinical trials, real-world value and evidence, as well as increased well-being for consumers.
Principles: Gotthardt Healthgroup AG observes highest ethical standards and the demanding German and European data privacy regulations. Gotthardt Healthgroup AG strives for excellence in execution in order to achieve a seamless integration of evidence in the respective workflows and thought processes for maximum impact.
Prof. Dr. Daniel Gotthardt
Chairman of the Supervisory Board
Prof. Dr. med. Daniel Gotthardt is managing director of Mediteo GmbH and also deputy chairman of the supervisory board of CompuGroup Medical SE. Prior he served as Senior Physician at the University Hospital Heidelberg, where he had been working for 13 years.
Dr. Tim Züwerink
Chief Executive Officer
Dr. Tim Züwerink is CEO of Gotthardt Healthgroup AG. Before he served as Senior Vice President of CompuGroup Medical AG and as project manager for McKinsey & Company, Inc., in their Frankfurt office, focusing on healthcare.
Dr. med. Steffen Achenbach
General Manager Research
For more than two decades, Dr. Achenbach has been working on both sides of Healthcare IT with many projects in patient care and Pharma R&D. He was Medical Director (Europe) for Microsoft and ultimately General Manager of CompuGroup Medical Research GmbH.